NICO Launches FDA Cleared Xenon Light Technology

NICO Myriad NOVUS Product Photo, Courtesy of NICO Corporation

Register to receive a free Operating Room Equipment Market Analysis, Size and Trends Report synopsis and brochure.

In a recent press release, the NICO Corporation introduced a neurosurgical product, which is the first of its kind, to the surgical microscope segment of the operating room equipment market. The Indianapolis-based interventional technologies developer has recently launched the NICO Myriad Novus.

The FDA-cleared device simultaneously uses xenon light and the Myriad resection tool, highlighting areas with precise lighting for surgical procedures. What makes Novus unique to the market is that it is the only device in the surgical microscope segment that offers automated and intraoperative tissue harvesting for surgeons to analyze post-procedure. Its functions include illumination, identification, resection, tissue collection and preservation.

In a recent in-depth study, iData Research has found that manufacturers are continually improving the quality and functionality of their surgical microscopes. This is necessary to justify the high pricing of the systems, as well as to entice facilities to upgrade their old microscopes. The introduction of 3D technology to the visualization system of surgical microscopes has increased the ASP, which tends to make the surgical microscopes intended for neurosurgery the most expensive. New innovations in this segment may potentially encourage facilities to update their equipment. This factor, alongside higher ASPs in devices like the NICO Myriad Novus, may facilitate positive growth in the surgical microscope market.

“The ability to optimally see what we’re doing, to safely resect lesions, and to automatically obtain and preserve tissue for pathologic and molecular analyses has been greatly enhanced by the advent of the NOVUS platform from NICO,” said Dr. Mark Rosenblum, Chairman Emeritus, Department of Neurosurgery at Henry Ford Health System.

Jim Pearson, President and CEO of NICO Corporation is “excited to give surgeons more versatility across minimally invasive port access, endoscopic, and skull base surgical approaches, while still addressing their needs surrounding procedural efficiencies and convenience.” The NOVUS will be premiered at booth #945 at the Congress of National Surgeons (CNS) Summit.


For Further Information

To get in an in-depth market overview, as well as insight through primary research and procedural volumes from 20 countries, please read iData Research’s’ 2454 page Operating Room Equipment Market Analysis, Size and Trends Report.

Leave a Reply